toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print

Warning: mysql_fetch_field() expects parameter 2 to be long, string given in /home/arimmora/public_html/refbase/includes/include.inc.php on line 309
  Records Links
Author Schuz, J.; Ahlbom, A. url  doi
openurl 
  Title Exposure to electromagnetic fields and the risk of childhood leukaemia: a review Type Journal Article
  Year 2008 Publication Radiation Protection Dosimetry Abbreviated Journal Radiat Prot Dosimetry  
  Volume 132 Issue 2 Pages 202-211  
  Keywords Body Burden; Child; *Electromagnetic Fields; Environmental Exposure/*statistics & numerical data; Humans; Incidence; Leukemia, Radiation-Induced/*epidemiology; Radiation Monitoring/statistics & numerical data; Risk Assessment/methods; Risk Factors; Young Adult  
  Abstract Extremely low-frequency magnetic fields have been classified as possibly carcinogenic to humans, mainly based on epidemiological studies consistently showing an association between long-term average exposures to magnetic fields above 0.3/0.4 microT and the risk of childhood leukaemia. No mechanism to explain this finding has been established and no support for a causal link emerged from experimental studies. Chance or bias cannot be ruled out with reasonable confidence as an explanation for the observed association. If the association is causal, it explains only a small fraction of childhood leukaemia cases. There were some reports of childhood leukaemia clusters in the vicinity of high-power radio and television broadcast transmitters in studies in Australia and Italy. However, recent large-scale systematic studies in Korea and Germany show no association between exposure to radio frequency electromagnetic fields emitted from broadcast towers and childhood leukaemia risk. Studies on mobile phone use and leukaemia risk in adolescents and young adults may be indicated.  
  Address Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark. joachim@cancer.dk  
  Corporate Author Thesis  
  Publisher (up) Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0144-8420 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:18927133 Approved no  
  Call Number CBM.UAM @ ccobaleda @ Serial 45  
Permanent link to this record
 

 
Author Sherborne, A.L.; Hosking, F.J.; Prasad, R.B.; Kumar, R.; Koehler, R.; Vijayakrishnan, J.; Papaemmanuil, E.; Bartram, C.R.; Stanulla, M.; Schrappe, M.; Gast, A.; Dobbins, S.E.; Ma, Y.; Sheridan, E.; Taylor, M.; Kinsey, S.E.; Lightfoot, T.; Roman, E.; Irving, J.A.E.; Allan, J.M.; Moorman, A.V.; Harrison, C.J.; Tomlinson, I.P.; Richards, S.; Zimmermann, M.; Szalai, C.; Semsei, A.F.; Erdelyi, D.J.; Krajinovic, M.; Sinnett, D.; Healy, J.; Gonzalez Neira, A.; Kawamata, N.; Ogawa, S.; Koeffler, H.P.; Hemminki, K.; Greaves, M.; Houlston, R.S. url  doi
openurl 
  Title Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk Type Journal Article
  Year 2010 Publication Nature Genetics Abbreviated Journal Nat Genet  
  Volume 42 Issue 6 Pages 492-494  
  Keywords Case-Control Studies; *Chromosomes, Human, Pair 9; *Genes, p16; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics  
  Abstract Using data from a genome-wide association study of 907 individuals with childhood acute lymphoblastic leukemia (cases) and 2,398 controls and with validation in samples totaling 2,386 cases and 2,419 controls, we have shown that common variation at 9p21.3 (rs3731217, intron 1 of CDKN2A) influences acute lymphoblastic leukemia risk (odds ratio = 0.71, P = 3.01 x 10(-11)), irrespective of cell lineage.  
  Address Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK  
  Corporate Author Thesis  
  Publisher (up) Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1061-4036 ISBN Medium  
  Area WP6 In vivo Expedition Conference  
  Notes PMID:20453839 Approved no  
  Call Number CBM.UAM @ ccobaleda @ Serial 46  
Permanent link to this record
 

 
Author Steliarova-Foucher, E.; Stiller, C.; Kaatsch, P.; Berrino, F.; Coebergh, J.-W.; Lacour, B.; Parkin, M. url  doi
openurl 
  Title Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study Type Journal Article
  Year 2004 Publication Lancet Abbreviated Journal Lancet  
  Volume 364 Issue 9451 Pages 2097-2105  
  Keywords Adolescent; Adult; Age of Onset; Child; Child, Preschool; Europe/epidemiology; Humans; Incidence; Infant; Neoplasms/*epidemiology/mortality; Registries; Survival Rate  
  Abstract BACKGROUND: Cancer is rare before age 20 years. We aimed to use the European database of childhood and adolescent cancer cases, within the Automated Childhood Cancer Information System project, to estimate patterns and trends of incidence and survival within Europe. METHODS: Comparable, high-quality data from 63 European population-based cancer registries consisted of 113000 tumours in children and 18243 in adolescents diagnosed in 1970-99. Incidence rates and survival were compared by region (east vs west), period, and malignant disease. FINDINGS: In the 1990s, age-standardised incidence rates were 140 per million for children (0-14 years) and 157 per million for ages 0-19 years. Over the three decades, overall incidence increased by 1.0% per year (p<0.0001) in children (increases for most tumour types), and by 1.5% (p<0.0001) in adolescents (15-19 years; notable increases were recorded for carcinomas, lymphomas, and germ-cell tumours). Overall 5-year survival for children in the 1990s was 64% in the east and 75% in the west, with differences between regions for virtually all tumour groups; 5-year survival was much the same in adolescents. Survival has improved dramatically since the 1970s in children and adolescents, more so in the west than in the east. INTERPRETATION: Our results are clear evidence of an increase of cancer incidence in childhood and adolescence during the past decades, and of an acceleration of this trend. Geographical and temporal patterns suggest areas for further study into causes of these neoplasms, as well as providing an indicator of progress of public-health policy in Europe.  
  Address International Agency for Research on Cancer, Lyon, France. steliarova@iarc.fr  
  Corporate Author Thesis  
  Publisher (up) Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0140-6736 ISBN Medium  
  Area WP9 Epidemiology Expedition Conference  
  Notes PMID:15589307 Approved no  
  Call Number CBM.UAM @ ccobaleda @ Serial 47  
Permanent link to this record
 

 
Author Trevino, L.R.; Yang, W.; French, D.; Hunger, S.P.; Carroll, W.L.; Devidas, M.; Willman, C.; Neale, G.; Downing, J.; Raimondi, S.C.; Pui, C.-H.; Evans, W.E.; Relling, M.V. url  doi
openurl 
  Title Germline genomic variants associated with childhood acute lymphoblastic leukemia Type Journal Article
  Year 2009 Publication Nature Genetics Abbreviated Journal Nat Genet  
  Volume 41 Issue 9 Pages 1001-1005  
  Keywords Alleles; Antimetabolites, Antineoplastic/metabolism/therapeutic use; Case-Control Studies; Child; Child, Preschool; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 7; Cohort Studies; DNA-Binding Proteins/genetics; Dopa Decarboxylase/genetics; European Continental Ancestry Group/genetics; Gene Dosage; Gene Expression Regulation, Neoplastic/drug effects; Gene Frequency; Genetic Predisposition to Disease; *Genetic Variation; Genome-Wide Association Study; *Germ Cells; Germ-Line Mutation; Haplotypes; Humans; Ikaros Transcription Factor/genetics; Linkage Disequilibrium; Methotrexate/metabolism/therapeutic use; Odds Ratio; Oncogene Proteins, Fusion/genetics; Polyglutamic Acid/metabolism; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma/*classification/drug therapy/*genetics; Probability; Reproducibility of Results; Risk Factors; Transcription Factors/genetics  
  Abstract Using the Affymetrix 500K Mapping array and publicly available genotypes, we identified 18 SNPs whose allele frequency differed significantly(P < 1 x 10(-5)) between pediatric acute lymphoblastic leukemia (ALL) cases (n = 317) and non-ALL controls (n = 17,958). Two SNPs in ARID5B not only differed between ALL and non-ALL groups (rs10821936, P = 1.4 x 10(-15), odds ratio (OR) = 1.91; rs10994982, P = 5.7 x 10(-9), OR = 1.62) but also distinguished B-hyperdiploid ALL from other subtypes (rs10821936, P = 1.62 x 10(-5), OR = 2.17; rs10994982, P = 0.003, OR 1.72). These ARID5B SNPs also distinguished B-hyperdiploid ALL from other subtypes in an independent validation cohort (n = 124 children with ALL; P = 0.003 and P = 0.0008, OR 2.45 and 2.86, respectively) and were associated with methotrexate accumulation and gene expression pattern in leukemic lymphoblasts. We conclude that germline variants affect susceptibility to, and characteristics of, specific ALL subtypes.  
  Address St. Jude Children's Research Hospital, Memphis, Tennessee, USA  
  Corporate Author Thesis  
  Publisher (up) Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1061-4036 ISBN Medium  
  Area WP6 In vivo Expedition Conference  
  Notes PMID:19684603 Approved no  
  Call Number CBM.UAM @ ccobaleda @ Serial 48  
Permanent link to this record
 

 
Author van Delft, F.W.; Horsley, S.; Colman, S.; Anderson, K.; Bateman, C.; Kempski, H.; Zuna, J.; Eckert, C.; Saha, V.; Kearney, L.; Ford, A.; Greaves, M. url  doi
openurl 
  Title Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia Type Journal Article
  Year 2011 Publication Blood Abbreviated Journal Blood  
  Volume 117 Issue 23 Pages 6247-6254  
  Keywords Child; Child, Preschool; Chromosomes, Human, Pair 16/*genetics/metabolism; Chromosomes, Human, Pair 6/*genetics/metabolism; Cyclin C; Cyclin-Dependent Kinase Inhibitor p15/genetics/metabolism; Cyclin-Dependent Kinase Inhibitor p16/genetics/metabolism; Female; Humans; Male; Oncogene Proteins, Fusion/*genetics/metabolism; Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics/metabolism/mortality/therapy; Recurrence; *Sequence Deletion; *Translocation, Genetic  
  Abstract B-cell precursor childhood acute lymphoblastic leukemia with ETV6-RUNX1 (TEL-AML1) fusion has an overall good prognosis, but relapses occur, usually after cessation of treatment and occasionally many years later. We have investigated the clonal origins of relapse by comparing the profiles of genomewide copy number alterations at presentation in 21 patients with those in matched relapse (12-119 months). We identified, in total, 159 copy number alterations at presentation and 231 at relapse (excluding Ig/TCR). Deletions of CDKN2A/B or CCNC (6q16.2-3) or both increased from 38% at presentation to 76% in relapse, suggesting that cell-cycle deregulation contributed to emergence of relapse. A novel observation was recurrent gain of chromosome 16 (2 patients at presentation, 4 at relapse) and deletion of plasmocytoma variant translocation 1 in 3 patients. The data indicate that, irrespective of time to relapse, the relapse clone was derived from either a major or minor clone at presentation. Backtracking analysis by FISH identified a minor subclone at diagnosis whose genotype matched that observed in relapse approximately 10 years later. These data indicate subclonal diversity at diagnosis, providing a variable basis for intraclonal origins of relapse and extended periods (years) of dormancy, possibly by quiescence, for stem cells in ETV6-RUNX1(+) acute lymphoblastic leukemia.  
  Address Section of Haemato-Oncology, Institute of Cancer Research, Sutton, UK  
  Corporate Author Thesis  
  Publisher (up) Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0006-4971 ISBN Medium  
  Area WP6 In vivo Expedition Conference  
  Notes PMID:21482711 Approved no  
  Call Number CBM.UAM @ ccobaleda @ Serial 49  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: